VEGFA and retinopathy of prematurity: Taking into consideration the incessant worldwide interest in the effects of treatment of severe ROP, especially with the use of anti-VEGF substances, coupled with a lack of uniform criteria in the literature for choosing the order of procedures—monotherapy or combined therapy—the authors of this article present their own long-term observations (mean 21.44 ± 8.69 months) of therapy conducted in various severe forms of ROP.